Lucid Diagnostics, a New York-based maker of diagnostic tests for esophageal precancer and cancer, filed for a $58 million IPO, per Axios. The pre-revenue company plans to list on the Nasdaq.
Lucid Files for $58M IPO
Related Posts
Apploi raises $25M in B Round
m]x[v Capital led the round.
CareAlign Raises $2.3M
The company offers a task management system for healthcare providers.
StroudwaterGCL Completes $58M in Financing for Towner County Medical Center in ND
The new facility will have 30 skilled nursing beds, five basic care beds and eight inpatient rooms.
Palta Closes $100M Series B Round Led by VNV Global: Report
This recent fundraising round will further help the company meet its goal of empowering 1 billion health-aware people via its ecosystem of innovative health and wellness products.